FXYD5 Downregulation Reverses Cisplatin Resistance in Ovaria
2026-06-02
A recent study demonstrates that silencing FXYD5 in epithelial ovarian cancer (EOC) cells restores cisplatin sensitivity, curbing proliferation and invasive behaviors. These findings clarify a potential therapeutic strategy for overcoming chemoresistance in EOC and highlight the utility of robust in vitro viability assays.
Applied Strategies Using Leptin (116-130), Amide, Mouse in O
2026-06-02
Leptin (116-130), amide, mouse, serves as a potent metabolic and immunological probe, uniquely bridging energy homeostasis research and inflammation models. This article delivers actionable protocols, advanced troubleshooting, and strategic insights to elevate translational studies in obesity, diabetes, and leptin signaling.
(-)-Epigallocatechin gallate (EGCG): Paradigm Shifts in Infl
2026-06-01
Explore how (-)-Epigallocatechin gallate (EGCG) advances inflammation modulation and apoptosis inhibition beyond conventional antioxidant research. This in-depth analysis reveals unique mechanistic strategies and protocol insights, setting a new benchmark for EGCG use in translational studies.
Dynamically Covalent Lipid Nanoparticles Enable Efficient CR
2026-06-01
Cao et al. introduce dynamically covalent lipid nanoparticles (LNPs) that efficiently deliver Cas9 mRNA and sgRNA for genome editing of VEGFA, providing a nonviral strategy to treat choroidal neovascularization (CNV) in mice. This work demonstrates improved mRNA delivery, targeted gene disruption, and sustained therapeutic effects, advancing the field of ocular gene therapy.
CXCR4-Targeted Imaging and Therapy in Lymphoma: Theranostic
2026-05-31
This review details how CXCR4-targeted imaging ligands enable integrated diagnosis and precision therapy in lymphoma. By dissecting the mechanistic rationale and translational potential of CXCR4 antagonism, the study guides researchers toward more effective and individualized approaches to managing aggressive hematologic malignancies.
PLK1 Regulation of p31comet and Mitotic Checkpoint Disassemb
2026-05-30
This study elucidates how PLK1 directly regulates the mitotic checkpoint by phosphorylating p31comet, thereby controlling the disassembly of mitotic checkpoint complexes (MCCs). The findings refine our mechanistic understanding of cell cycle progression and offer new avenues for targeted cancer research, particularly in designing strategies to modulate mitotic checkpoint inactivation.
MLN4924 HCl Salt: Unlocking NEDD8-Activating Enzyme Inhibiti
2026-05-29
MLN4924 HCl salt enables precise, reproducible inhibition of the neddylation pathway, making it indispensable for dissecting ubiquitin-mediated protein turnover in cancer, inflammatory, and viral infection models. This guide details optimized workflows, troubleshooting strategies, and advanced applications that leverage MLN4924 HCl salt’s selectivity and potency.
G007-LK Tankyrase 1/2 Inhibitor: Wnt/β-Catenin Pathway Contr
2026-05-29
G007-LK is a potent, selective tankyrase 1/2 inhibitor that modulates the Wnt/β-catenin signaling pathway and induces β-catenin degradation in APC-mutant colorectal cancer models. Its efficacy is supported by nanomolar IC50 values and in vivo tumor suppression. APExBIO offers G007-LK for research applications requiring precise Wnt pathway inhibition.
QX77: Molecular Chaperone Activator for Autophagy Workflows
2026-05-28
QX77 enables precise upregulation of chaperone-mediated autophagy by targeting LAMP2A and Rab11, offering robust solutions for dissecting autophagic flux and stem cell differentiation. This article details applied workflows, troubleshooting strategies, and the unique comparative strengths of QX77 in autophagy pathway modulation.
5-Ethynyl-2'-deoxyuridine (5-EdU): Decoding Neurodevelopment
2026-05-28
Explore the unique role of 5-Ethynyl-2'-deoxyuridine (5-EdU) in dissecting cell proliferation and neurodevelopmental impairments. This article uncovers advanced applications and assay insights distinct from standard protocols.
VX-745: Strategic p38α MAPK Inhibition for Translational Imp
2026-05-27
Explore the dual-action mechanism and translational strategy of VX-745, a highly selective p38α MAPK inhibitor, with insight into kinase dephosphorylation, inflammation, and oncology models. This article bridges mechanistic advances, assay protocols, and strategic guidance for researchers aiming to unlock next-generation therapeutic paradigms.
Diethylmaleate: Redefining Redox Modulation and Resistance R
2026-05-27
Explore the advanced scientific applications of Diethylmaleate as an oxidative stress research chemical. This article delivers a unique, in-depth analysis of its role in dissecting redox regulation and resistance mechanisms, offering fresh insights for toxicology and reproductive system studies.
Strategic BCL-XL Inhibition: WEHI-539 in Translational Oncol
2026-05-26
This thought-leadership article explores how WEHI-539, a highly selective BCL-XL inhibitor from APExBIO, advances apoptosis research and translational oncology by enabling precise dissection of survival pathways, overcoming chemoresistance in cancer stem cells, and supporting the design of next-generation combination therapies. Integrating mechanistic insights, recent literature, and strategic guidance, the article offers researchers a roadmap for leveraging WEHI-539 beyond conventional product applications.
Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Practica
2026-05-26
The Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) prevents protein degradation during extraction by inhibiting a wide range of endogenous proteases, making it suitable for workflows requiring mass spectrometry compatibility. It should not be used for metalloproteinase inhibition unless supplemented with EDTA, and is not appropriate where AEBSF-sensitive protease inhibition is required.
Fluo-4 AM in Disease Mechanism Discovery: Precision Calcium
2026-05-25
Explore how Fluo-4 AM, a leading fluorescent calcium indicator, empowers high-resolution intracellular calcium studies in complex disease models. This article delivers unique insights into mechanistic research, protocol optimization, and practical assay choices.
466 records 17/32 page Previous Next First page 上5页 1617181920 下5页 Last page